Following is a summary of current health news briefs.

EU regulator endorses Takeda's dengue vaccine

The European drugs regulator on Friday recommended a dengue vaccine from Japan's Takeda, paving the way for a second vaccine for the mosquito-borne disease that causes millions of infections annually. European Medicines Agency (EMA) advisors backed the use of the Takeda vaccine for those aged 4 and older to prevent any of the four so-called serotypes of dengue.

Biden takes aim at Big Pharma, Republicans in California

U.S. President Joe Biden criticized Republicans and drug companies during a stop at a California community college on Friday as he campaigned for fellow Democrats in November's midterm elections. Biden's trip includes stops in California on Friday and Oregon on Saturday as the president looks to position his party, the Democrats, as a champion of consumers and lower healthcare costs at a time that inflation ranks among voters' top concerns. The midterm elections are on Nov. 8.

U.S. Supreme Court rebuffs Novartis, allows generic versions of MS drug

The U.S. Supreme Court on Thursday turned down Novartis' bid to block the launch of generic versions of the company's blockbuster multiple sclerosis drug Gilenya in a dispute with China's HEC Pharm Co Ltd and other generic drugmakers. Novartis had asked the justices to suspend a lower court's ruling that lifted a ban on generic versions of Gilenya, the Switzerland-based company's third highest-selling drug last year with $2.8 billion in sales.

Exclusive-NHS drafts stricter oversight of trans youth care

England's National Health Service has drafted new guidelines for treating transgender youth that would call for local authorities to be alerted in some cases where young people have obtained puberty blockers and hormone therapies on the private market, according to a copy of the guidelines reviewed by Reuters. The guidelines are part of a wide-ranging review of treatment for young transgender people seeking NHS care. The current approach, which can include medical interventions, has been criticized by some practitioners who said it rushed people onto medication, and by families who complained the service could not manage fast-growing demand.

Japan's Fujifilm stops work on Avigan as COVID drug

Fujifilm Holdings Corp has ended the development of its anti-influenza drug Avigan to treat COVID-19, the firm said on Friday, after more than two years of work on a pill once hailed as Japan's biggest contribution to the global coronavirus fight.

In March, Fujifilm had cut short enrolment in a Phase III trial, saying the emergence of the Omicron variant made it tough to measure the drug's effectiveness in preventing severe symptoms.

China says its zero-COVID policy is the best, most cost-effective, will improve

China's COVID-19 measures are the best, most cost-effective and will continue to improve, a spokesman for the ruling Communist Party said on Saturday. "We firmly believe that the light is ahead and perseverance is victory," Sun Yeli told a news conference in Beijing ahead of the party's 20th congress.

Long COVID at 12 months persists at 18 months, study shows

Most patients with COVID-19 who have lingering symptoms at 12 months are likely to still have symptoms at 18 months, new data suggest. The findings are drawn from a large study of 33,281 people in Scotland who tested positive for the coronavirus. Most of the results are in line with those from earlier, smaller studies.

Uganda introduces lockdown measures to halt spread of Ebola: President

Uganda President Yoweri Museveni said on Saturday the government was implementing an overnight curfew, closing places of worship and entertainment, and restricting movement into and out of two districts affected by Ebola for 21 days. The measures aimed at curbing the spread of the disease will be introduced immediately in Mubende and Kassanda districts in central Uganda, the epicenter of the epidemic, he said in a televised national address.

China reports 1,026 new COVID cases for Oct 15 vs 1,364 a day earlier

China reported 1,026 new COVID-19 infections for Oct. 15, of which 244 were symptomatic and 782 were asymptomatic, the National Health Commission said on Sunday. That compared with 1,364 new cases a day earlier - 361 symptomatic and 1,003 asymptomatic, which China counts separately.

Abbott recalls some liquid baby formula over bottle defect

 

Abbott Laboratories said on Friday it was recalling some ready-to-feed baby formula liquid products including Similac-branded items due to inadequate sealing of some bottle caps. The recall, which equates to less than one day's worth of infant formula used in the United States, is not expected to impact the overall formula supply, Abbott said in a statement.

The longevity diet is a set of eating recommendations compiled by a biochemist called Valter Longo, director of the University of Southern California’s Longevity Institute. He is known for his research on the role of fasting, the effects of nutrients on your genes and how these may impact ageing and the risk of diseases.

While the longevity diet has been targeted to older adults, it is also recommended for younger people. Longo has said he plans to live to 120 by following this diet.

So, what does the diet look like?

Foods in this diet are vegetables, including leafy greens, fruit, nuts, beans, olive oil, and seafood that’s low in mercury.

So most foods in the longevity diet are plant based. Plant-based diets are generally higher in vitamins and minerals, dietary fibre, antioxidants and lower in saturated fat and salt, which lead to health benefits.

Foods that are discouraged are an excess of meat and dairy, and those high in processed sugar and saturated fats.

 

For people who don’t want to go without dairy, the longevity diet recommends switching from cow’s milk to either goat’s or sheep’s milk, which have a slightly different nutrient profile. But there is little evidence sheep’s and goat’s milk provide more health benefits.

Including fermented dairy (such as cheese and yoghurt) in your diet, as recommended in the longevity diet, is beneficial as it provides a more extensive microbiome (good bacteria) than any milk.

Have you seen this diet before?

Many of you may recognise this as a familiar dietary pattern. It is similar to the Mediterranean diet, especially as both feature olive oil as the oil of choice. The Mediterranean diet is promoted and backed by a considerable body of evidence to be health promoting, reducing the risk of disease, and promoting longevity.

The longevity diet is also similar to many national, evidence-based dietary guidelines, including Australia’s.

Two-thirds of the recommended foods in the Australian dietary guidelines come from plant-based foods (cereals, grains, legumes, beans, fruits, vegetables). The guidelines also provide plant-based alternatives for protein (such as dried beans, lentils and tofu) and dairy (such as soy-based milks, yoghurts and cheeses, so long as they are supplemented with calcium).

Intermittent fasting

Another aspect of the longevity diet is the specified periods of fasting, known as intermittent fasting. The diet advocates eating in a 12-hour time-frame, and not eating for three to four hours before bed time.

Typically with intermittent fasting people fast for 16–20 hours with a four to eight hour window of eating. Another intermittent fasting option is the 5:2 diet, in which eating is restricted to about 2,000–3,000 kilojoules for two days of the week and for the other five days, eating normally.

The evidence indicates intermittent fasting may lead to improvements in insulin resistance, which leads to better blood glucose control. This can reduce your risk of type 2 diabetes and other chronic diseases, such as heart disease and obesity.

Maintain a healthy weight

The longevity diet recommends that people who are overweight eat only two meals a day – breakfast and either a midday or evening meal – plus just two low-sugar snacks. This is to try to reduce kilojoule intake for weight loss.

Another important aspect of this recommendation is to reduce snacking, particularly of foods high in saturated fat, salt or sugar. These are the foods we typically refer to as discretionary/sometimes foods, or ultra-processed foods. These offer little nutritional value, and in some cases are linked to worse health outcomes.

Eat a rainbow of colours

The longevity diet recommends eating foods rich in nutrients, which most national dietary guidelines also advocate. This means eating a diet rich in plant foods, and a variety of foods within each food group.

Each colour fruit and vegetable contains different nutrients, so eating a range of coloured fruit and vegetables is recommended. The recommendation to select a range of wholegrains over refined cereals, breads, pasta and rice also reflects the best nutritional evidence.

Restrict protein intake

This diet recommends a restricting protein intake to 0.68-0.80g per kilogram of body weight per day. This is 47-56g of protein a day for a 70kg person. For reference each of these foods contains about 10g of protein: two small eggs, 30g cheese, 40g lean chicken, 250mL dairy milk, 3/4cup lentils, 120g tofu, 60g nuts or 300mL soy milk. This is in line with government recommendations.

Most Australians easily consume this level of protein in their diet. However it is the elderly population, to whom the longevity diet is targeted, who are less likely to meet their protein requirements.

In the longevity diet it is recommended most of the protein comes from plant sources or fish. This may require special planning to ensure a complete range of all the nutrients needed if the diet is missing red meat.

Are there any problems with this diet?

This diet recommends taking a multivitamin and mineral supplements every three to four days. Longo says this prevents malnourishment and won’t cause any nutritional problems.

However, many health bodies including the World Cancer Research Fund, the British Heart Foundation and the American Heart Association do not recommend taking supplements to prevent cancer or heart disease.

Supplements should only be taken on your doctor’s advice, following a blood test showing a deficiency in a specific nutrient. This is because some vitamins and minerals may be harmful in high quantities.

If you are eating a variety of foods across all food groups, you are meeting all your nutrient requirements and shouldn’t need supplements.

The verdict?

This longevity diet is a compilation of many aspects of evidence-based healthy eating patterns. We already promote these as they improve our health and reduce the risk of developing chronic diseases. All of these aspects of healthy eating could lead to increased longevity.

What’s not mentioned in the longevity diet is the importance of exercise for good health and a long life.

 

New Delhi: Researchers at the Indian Institute of Technology (IIT), Delhi have developed SARS-CoV-2 Virus-Like Particles (VLPs), which are a possible vaccine candidate against COVID-19, according to officials.

The VLPs tricked the immune system into launching a counter-attack in mice, just as it does against SARS-CoV-2, they said.

“The majority of the VLPs developed worldwide have utilised only the spike protein of SARS-CoV-2 as the primary antigen. However, our VLPs are as native virus-like as possible, which means they contain all four structural proteins from SARS-CoV-2 (s – spike, n – nucleocapsid, m – membrane, e – envelope),” said Manidipa Banerjee, lead researcher and professor at IIT-Delhi’s Kusuma School of Biological Sciences.

“Vaccines based on an inactivated virus naturally have this advantage. However, VLPs are safer as they are non-infectious due to a lack of genome. This could be an advantage in case there are several mutations in ‘spike’ in any variant, which preclude the binding of neutralising antibodies. Animal experiments carried out at THSTI indicate that our VLPs trigger a strong adaptive immune response against multiple antigens,” she added.

The researchers have worked in collaboration with a team from the Translational Health Science and Technology Institute (THSTI), Faridabad, Haryana.

The study, titled “Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity and Internalisation in Neuronal Cells”, was recently published in the “ACS Infectious Diseases” journal.

According to the officials, since the outbreak of the Covid pandemic, researchers are trying to get a better understanding of the SARS-CoV-2 virus and developing vaccines against it.

“Vaccines offer a great deal of protection against the virus, but some people who have received the shots still catch COVID-19. To develop even better vaccines and treatments, ideally, experiments need to be conducted with the real virus, which can only be handled in very specialised laboratories.

“Working with live viruses can put personnel at risk and the requirement for specially-designed settings can limit the scope of research that some teams can perform. Instead, a safer and easier strategy is to use VLPs which are molecular mimics that look and act like a certain virus without being infectious. The particles can even serve as a vaccine themselves, as is the case with two that are currently available against the human papillomavirus,” Banerjee said.

The researchers and their collaborators have also utilised these VLPs to understand how SARS-CoV-2 could be invading cells in the central nervous system (CNS).

“COVID-19, while well-known as a respiratory illness, can also affect the nervous system, bringing on headaches and fatigue and wiping out the sense of smell, but it is unclear how these symptoms are caused. The research showed that the VLPs could get into brain cells in petri dishes and the process depended on both cholesterol in the cell membrane and an enzyme called dynamin,” Banerjee said.

 ANI

Washington, October 19

Women who used chemical hair straightening products were at higher risk for uterine cancer compared to women who did not report using these products, according to a new study. The researchers found no associations with uterine cancer for other hair products that the women reported using, including hair dyes, bleach, highlights, or perms.

The study data includes 33,497 U.S. women ages 35-74 participating in the Sister Study, a study led by the National Institute of Environmental Health Sciences (NIEHS), part of NIH, that seeks to identify risk factors for breast cancer and other health conditions. The women were followed for almost 11 years and during that time 378 uterine cancer cases were diagnosed.

The researchers found that women who reported frequent use of hair straightening products, defined as more than four times in the previous year, were more than twice as likely to go on to develop uterine cancer compared to those who did not use the products.

"We estimated that 1.64% of women who never used hair straighteners would go on to develop uterine cancer by the age of 70; but for frequent users, that risk goes up to 4.05%," said Alexandra White, Ph.D., head of the NIEHS Environment and Cancer Epidemiology group and lead author on the new study. "This doubling rate is concerning. However, it is important to put this information into context -- uterine cancer is a relatively rare type of cancer."

Uterine cancer accounts for about 3% of all new cancer cases but is the most common cancer of the female reproductive system, with 65,950 estimated new cases in 2022. Studies show that incidence rates of uterine cancer have been rising in the United States, particularly among Black women.

Approximately 60% of the participants who reported using straighteners in the previous year were self-identified Black women, according to the study published in the Journal of the National Cancer Institute. Although, the study did not find that the relationship between straightener use and uterine cancer incidence was different by race, the adverse health effects may be greater for Black women due to higher prevalence of use.

"Because Black women use hair straightening or relaxer products more frequently and tend to initiate use at earlier ages than other races and ethnicities, these findings may be even more relevant for them," said Che-Jung Chang, Ph.D., an author on the new study and a research fellow in the NIEHS Epidemiology Branch.

The findings are consistent with prior studies showing straighteners can increase the risk of hormone-related cancers in women.

The researchers did not collect information on brands or ingredients in the hair products the women used. However, in the paper they note that several chemicals that have been found in straighteners (such as parabens, bisphenol A, metals, and formaldehyde) could be contributing to the increased uterine cancer risk observed. Chemical exposure from hair product use, especially straighteners, could be more concerning than other personal care products due to increased absorption through the scalp which may be exacerbated by burns and lesions caused by straighteners.

"To our knowledge this is the first epidemiologic study that examined the relationship between straightener use and uterine cancer," said White. "More research is needed to confirm these findings in different populations, to determine if hair products contribute to health disparities in uterine cancer, and to identify the specific chemicals that may be increasing the risk of cancers in women." This team previously found that permanent hair dye and straighteners may increase breast and ovarian cancer risk.  

 After 30, without proper maintenance, bones, muscles and joints weaken and deteriorate. The age of 50 acts as a cutoff. After that, 50 per cent of men and women experience pain. It may be present occasionally or be constant and nagging, interfering with their daily activities. Incapacitating, long-lasting, daily pain is more likely if other lifestyle diseases, worries or depression are also present.

 Washington [US], October 17 (ANI): The findings of recent research suggest that certain hospital room features, such as having a window view and distance from a nursing station, may influence clinical outcomes after undergoing high-risk operations.

The findings were presented at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022.

Each year, about USD 50 billion is spent on the construction of healthcare facilities in the United States. Architecture and interior design can enhance patient care and outcomes. A seminal comparative study published in Science in 1984 revealed that having a window view may influence recovery from surgery, and additional research has found that severely ill patients who are assigned to ICU rooms that are not well visualized by the medical staff may experience worse outcomes.

However, little research has investigated how room features such as single versus double occupancy, distance from a nursing station, and a window view may impact clinical outcomes. Researchers at the University of Michigan sought to understand whether certain hospital room features impact mortality and length of stay after surgery.

“We were fascinated to see from a previous study that mortality was different in rooms that were in the line of sight of a nurse’s station. Nurses could more readily assess the patient’s condition and intervene more quickly in severe events. We wanted to see how this finding would play out at our institution, specifically in a surgical population,” said study coauthor Mitchell J. Mead, a health and design scholar at the University of Michigan.

He added, “One of the next big steps for health care design is to understand these pathways of causation that can lead to different clinical outcomes in patients staying in hospital rooms with different features.”

The analysis for this single-site study involved 3,964 patients who underwent 13 high-risk surgical procedures (including colectomy, pancreatectomy, and kidney transplant) at the University of Michigan Hospital between 2016 and 2019. The patients were admitted to rooms on two hospital floors.

Patient rooms were coded based on their features–window or no window, single occupancy, double occupancy, distance to the nursing station, and line of sight to clinicians. Patient encounters were linked by room number to identify clinical outcomes, including mortality and length of stay, related to room design.

Key findings

Mortality rates for high-risk procedures varied across room design features and room types.

Room features that influenced clinical outcomes after surgery included distance from a nursing station, single room occupancy, and having a direct line of sight where clinicians can see into the room.

After adjusting for patient comorbidities and the complexity of the operation, mortality rates were 20 per cent higher (odds ratio 1.2) if patients were admitted to a hospital room without a window than if they were put in a room with a window.

For patients staying in a room without a window, 30-day mortality rates were 10 per cent higher (odds ratio 1.1).

Though mortality rates varied across room design, mortality rates did not vary by room type after accounting for the length of stay, suggesting that length of stay does not account for differences in mortality.

“This investigation provided evidence that patients had differential outcomes across room design features, when accounting for clinical risk, and warrants further investigation for how hospital design may be influencing outcomes,” Mr Mead said.

When the authors looked at different rooms based on the favourable design features, it became clear that the sicker patients were more likely to get single rooms, closer to a nursing station and within direct line of sight, and a window view, added study coauthor Andrew M. Ibrahim, MD, MSc, assistant professor of surgery, architecture, and urban planning at the University of Michigan and co-director of the Center for Outcomes and Policy.

Dr Ibrahim noted that this study is just one example illustrating the often-overlooked relationship between hospital design and patient care. Investing in research to figure out what design features work best may be one key factor in improving patient outcomes. “I think we can get a much better return on what we build and hopefully design safer healthier hospitals,” he said.

Future studies should investigate these outcomes at multiple hospitals to find out if the results are generalizable, the authors suggest. They are in the process of replicating a similar study across Michigan Medicine and hope to recruit collaborators across other hospital systems.

In addition, the researchers hope to expand their study to include other metrics like the use of pain medication and patient satisfaction across these room types.

“The common question we get asked is, do you want us to rebuild our hospitals? Of course, that is not practical. But we do recognize clear patterns where certain room types have better outcomes after surgery,” Dr Ibrahim said. “We can start to prioritize the sickest patients there. Just the way we have developed precision health models for getting the right care to the patient, there may be a corollary for the right room for the right patient and procedure to optimize outcomes collectively.” (ANI)

 PTI

 

New Delhi, October 16

The government’s Covid vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering Rs 4,237 crore, or nearly 85 per cent of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry.

Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre and in states and the stock is sufficient to continue the vaccination drive for around six months, given the low uptake of vaccines among people due to declining Covid case burden.

Even if the government’s stock gets exhausted, Covid vaccines will be available in the market.

“Any decision on whether to procure Covid vaccine doses through the government channel or get (fresh) budget allocations for the purpose after six months will depend on the coronavirus situation prevailing in the country at that time,” an official source told PTI.

As part of the nationwide vaccination drive which began on January 16 last year, the Government of India has been supporting states and Union territories by providing them COVID-19 vaccines free of cost.

Since the Covid cases have been low, a sense of complacency has grown among people and there has not been much demand of vaccines even though the government conducted a 75-day drive—‘Covid Vaccination Amrit Mahotsava’—to administer booster doses to all adults free of cost.

“Considering this and the vaccines in the stockpile nearing their expiry date, the decision has been taken not to procure any more vaccines for now. Also, the Union Health Ministry has surrendered to the Finance Ministry the balance of Rs 4,237.14 crore from its 2022-23 budget allocation of Rs 5,000 crore for inoculation purposes,” the source said.

The cumulative Covid vaccine doses administered in the country has crossed 219.32 crore, according to provisional reports till 7 am on Sunday.

Official sources said 98 per cent of India’s adult population has received at least one dose of the COVID-19 vaccine while 92 per cent have been fully vaccinated.

Besides, 83.7 per cent of adolescents aged 15 to 18 years have been vaccinated with the first dose since the vaccination for this age group began on January 3, while 72 per cent have got both the first and second doses.

In the age-group of 12-14 years, 87.3 per cent have been administered the first dose while 68.1 per cent are fully vaccinated.

Of the total eligible target population of 18 years and above, a little over 27 per cent have been administered precaution doses so far.

The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase. Vaccination of frontline workers started from February 2 last year.

The next phase of COVID-19 vaccination commenced on March 1 last year for people over 60 years of age and those aged 45 and above with specified comorbid conditions.

Vaccination for all people aged more than 45 years began on April 1 last year. The government then decided to expand the ambit of the vaccination drive by allowing everyone above 18 years to be inoculated against Covid from May 1 last year.

Inoculation of adolescents in the age group of 15-18 years commenced on January 3.

India began administering precaution doses of vaccines to healthcare and frontline workers and those aged 60 and above with comorbidities from January 10.

The country began inoculating children aged 12-14 from March 16 and also removed the comorbidity clause making all people aged above 60 eligible for the precaution dose of Covid vaccine.

India on April 10 began administering precaution doses of COVID-19 vaccines to all aged above 18 years.

The cumulative vaccine doses administered in the country crossed the 100-crore mark on October 21 last year and 150 crore on January 7 this year. The total doses administered in the country surpassed the 200-crore mark on July 17.

London, October 14

A new study headed by UCL academics revealed that people living with dementia who suffer from anxiety or despair may benefit from talking therapies provided on the NHS.

Mental health problems such as depression and anxiety are very common in people with dementia, and previous studies estimate that 38% of people with mild dementia are affected by the conditions.

However, the new study, published in eClinicalMedicine, is the first to assess whether talking therapies that are routinely delivered within healthcare settings might be helpful to relieve symptoms.

Researchers examined data from 2,515,402 people, who had clinically significant anxiety or depression and completed a course of treatment via the national 'Improving Access to Psychological Therapies' (IAPT) service in England between 2012 and 2019.

IAPT is a free NHS service and offers evidence-based therapies for treating anxiety and depression, including CBT (cognitive behavioural therapy), counselling and guided self-help, with sessions delivered either face-to-face individually, in groups, or online.

To be counted in the study, participants had to have either: Clinical levels of depressive symptoms as measured using a standard questionnaire* which considers factors such as a lack of interest in doing things, issues with sleep, and feelings of low mood.

Clinical levels of anxiety based on a standard measure** which asks patients questions about how much they worry or have trouble relaxing.

To examine outcomes for people living with dementia, the researchers looked at all those who had a dementia diagnosis before starting IAPT treatment -- which was 1,549 people.

They also used a control group of 1,329 people to assess whether therapy outcomes for those living with dementia differed from those without dementia, by selecting a group of people from the full dataset who were similar to the people with dementia in terms of age, gender, depression and anxiety severity when starting treatment.

The researchers found that among people with dementia, the treatment proved to be clinically beneficial and 63% of them saw a reduction in symptoms of depression and anxiety, following IAPT. Meanwhile, approximately 40% recovered completely.

Comparatively, in the control group, 70% of participants saw an improvement in symptoms and 47% recovered.

Lead author, PhD candidate Georgia Bell (UCL Psychology & Language Sciences), said: "Anxiety and depression are very common in people with dementia. They are extremely debilitating and associated with worse outcomes for both the person with dementia and their carers.

"This is the largest ever study to investigate outcomes of psychological therapies in people living with dementia. Our findings suggest that while people with dementia are less likely to improve or recover than those without dementia, psychological therapies offered in primary care mental health services can be beneficial for them.

"Consequently, our findings support the use of IAPT to treat anxiety and depression in people with dementia. We hope this study will have implications for encouraging referrals and adaptations to increase access and enhance outcomes for people living with dementia." Previously, there was limited evidence that talking therapies were adequately effective for people with dementia, but a review of evidence led by UCL researchers confirmed their efficacy earlier this year.*** This latest study adds to that, by confirming that NHS treatment offerings can confer such a benefit.

The study was funded by the Alzheimer's Society and Wellcome.

Dr Richard Oakley, Associate Director of Research at Alzheimer's Society, said: "Many people living with dementia also have depression and anxiety, making it even harder for them and their carers to cope with symptoms and for some people even leading to a faster decline in memory and thinking problems. Consistent and accessible mental health support after a diagnosis is vital.

"This Alzheimer's Society-funded research is the first study looking at the effectiveness of therapy for people living with dementia in a real-world setting. It showed that people living with dementia showed a significant improvement in symptoms of anxiety and depression when treated with therapy, even though their response wasn't as strong as that shown in the general population.

"This research underpins the importance of timely access to mental health support, as revealed in our recent Left To Cope Alone report. We found 61% of people affected by dementia are currently in need of mental health support, and yet, in 2018, of 1 million annual referrals to Improving Access to Psychological Therapies (IAPT) services, just 0.2% were for people with dementia.

"Though this study didn't compare the types of therapy, types of dementia, or if there were adaptations made for people living with the disease, it still highlights the urgent need to improve real-world therapy for those living with dementia - with adaptations to improve its effectiveness and accessibility.

"Alzheimer's Society can provide advice, emotional support, and guidance for those living with, or affected by the condition. Visit alzheimers.org.uk or call 0333 150 3456."

Study limitations

Researchers were unable to infer causal relationships between receiving therapy and having an improvement in symptoms as the study was observational in nature and a randomised control design would be needed to establish this causality. Furthermore, while there is evidence to suggest that questionnaires for measuring anxiety and depression can be validly completed by people with dementia, the anxiety scale used has not been validated for use in a sample of people living with dementia meaning it may not accurately measure anxiety. 

Researchers could also not distinguish the type of therapy given to the patients during their IAPT treatment so it is unclear whether one type of therapy may be better than any other in treating anxiety and depression in people living with dementia.

Additionally, the identification of people living with dementia was based on linked records, so some who attended IAPT may have been missed. And the severity of dementia could also not be accounted for at the time of psychological treatment. (ANI) 

 

 Alberta [Canada], October 14 (ANI): A recent study has revealed the role of dietary fiber and gut microbes in people with inflammatory bowel disease, a finding which could lead to personalized dietary guidelines.
The research team discovered that certain types of dietary fibre cause an inflammatory response in some patients, causing symptoms to worsen. They are now working to develop a stool test to examine the microbes found in each patient's gut in order to predict who will have a negative response, so they can tailor dietary recommendations and treatment for individual patients.
Approximately 0.7 per cent of Canada's population, or one in 150 people, has IBD, including Crohn's disease and ulcerative colitis, and that is predicted to grow to one per cent by 2030.
IBD symptoms may include abdominal pain, diarrhea, bloody stools, weight loss, late puberty, and a long-term risk of colorectal cancer. The exact cause is unknown, but some risk factors include genetics, diet, environmental factors and changes in the gut microbes.
"We know there are health benefits to consuming dietary fibres and they promote good gut health in healthy individuals, but IBD patients quite frequently complain about a sensitivity when they consume dietary fibres," says Heather Armstrong, who started the research as a postdoctoral researcher at the U of A and is now an assistant professor of internal medicine at the University of Manitoba and Canada Research Chair in Integrative Bioscience. "We really wanted to understand the mechanisms behind this."
"By creating this stool test, we are hoping to be able to tell you how to adjust your diet to prevent flares or further worsening," says Eytan Wine, a professor in the U of A's Faculty of Medicine & Dentistry. "It's a dynamic situation so it's possible that a certain food you should avoid now, in a few months you'll be okay to eat that again."
The researchers have identified that specific types of fibres found in foods such as artichoke, chicory roots, garlic, asparagus, and bananas, are especially hard to ferment if certain microbes are missing or malfunctioning, as is often the case for IBD patients.
Fibre has a beneficial anti-inflammatory effect in most healthy people and aids with digestion, but researchers have found that select unfermented fibres actually increase inflammation and worsen symptoms in some IBD patients.
"We want to start uncovering why it is that 20 to 40 per cent of patients experience sensitivity," says Armstrong, "while in the other portion of patients these dietary fibres can actually benefit health and protect against the disease and have very positive effects." (ANI)

Washington [US], October 12 (ANI): New research shows that older adults may be better supported as they age when their personalities are considered, for example, are they more like orchids or dandelions? Researchers examined the potential effects of lifestyle activities on the cognitive health of more than 3,500 adults aged 60+. They found that personality using psychology's orchid-dandelion metaphor can be a factor in how well supportive programs work.
Researchers from Simon Fraser University's Circle Innovation examined the potential effects of lifestyle activities on the cognitive health of more than 3,500 adults aged 60+. They found that personality-using psychology's orchid-dandelion metaphor can be a factor in how well supportive programs work. Their results, published this month in the journal Frontiers in Aging Neuroscience, make a case for policy-makers to consider designing programs tailored to personality types rather than a one-size-fits-all approach.
"These discoveries offer new possibilities to support aging adults and provide substantial evidence for new social prescribing programs," says Circle Innovation CEO and scientific director Sylvain Moreno. "Understanding how personality differences affect an aging population can help decision-makers provide older adults with solutions that fit their individual needs."
People who may be considered 'orchid adults' thrive best under ideal circumstances, since they are more sensitive and biologically reactive, while 'dandelion adults' are thought to be resilient and can easily adapt to any environment.
That means orchid individuals could require more nurturing solutions, researchers say. "These older adults are more fragile, like the delicate flower they represent, and hence prone to overreact to ongoing health and housing problems, disturbing news about the economy or global pandemics," says SFU PhD student and study researcher Emma Rodrigues. "On the other hand, dandelion retirees are relatively less environment-sensitive and also more resilient to deterioration in poor environmental conditions."
"The lesson here is that weshould stop pigeonholing aging adults into one group of our population. These results demonstrate how aging trajectories can differ depending on whether the environment influences a person."
According to researchers, understanding how modifiable lifestyle factors may maintain or promote cognitive health can lead to a healthier aging population. (ANI)